DENTSPLY SIRONA Inc. to Post Q2 2024 Earnings of $0.51 Per Share, Zacks Research Forecasts (NASDAQ:XRAY)

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Investment analysts at Zacks Research dropped their Q2 2024 earnings per share estimates for shares of DENTSPLY SIRONA in a research report issued to clients and investors on Thursday, May 23rd. Zacks Research analyst I. Bandyopadhyay now forecasts that the medical instruments supplier will post earnings of $0.51 per share for the quarter, down from their prior forecast of $0.53. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $2.03 per share. Zacks Research also issued estimates for DENTSPLY SIRONA’s Q4 2024 earnings at $0.57 EPS, FY2024 earnings at $2.01 EPS, Q4 2025 earnings at $0.66 EPS and FY2025 earnings at $2.34 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, hitting the consensus estimate of $0.42. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The business had revenue of $953.00 million for the quarter, compared to analysts’ expectations of $969.45 million. During the same quarter in the previous year, the firm earned $0.39 earnings per share. The business’s revenue was down 2.6% on a year-over-year basis.

Other analysts have also issued research reports about the stock. Robert W. Baird lowered their price objective on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating on the stock in a research report on Friday, May 3rd. Needham & Company LLC dropped their price objective on DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating on the stock in a research note on Friday, May 3rd. StockNews.com downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday, May 3rd. Piper Sandler reaffirmed a “neutral” rating and set a $32.00 price target (down previously from $35.00) on shares of DENTSPLY SIRONA in a research report on Friday, May 3rd. Finally, The Goldman Sachs Group decreased their price objective on DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating for the company in a report on Monday, May 6th. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, DENTSPLY SIRONA has a consensus rating of “Moderate Buy” and an average price target of $35.22.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $27.46 on Monday. The company has a market capitalization of $5.70 billion, a P/E ratio of -62.41, a price-to-earnings-growth ratio of 1.22 and a beta of 1.00. The company’s 50-day moving average is $30.52 and its 200 day moving average is $32.44. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.97 and a current ratio of 1.43. DENTSPLY SIRONA has a fifty-two week low of $26.27 and a fifty-two week high of $41.65.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Principal Securities Inc. bought a new position in shares of DENTSPLY SIRONA in the fourth quarter valued at approximately $26,000. VisionPoint Advisory Group LLC lifted its stake in DENTSPLY SIRONA by 104.2% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 395 shares in the last quarter. Headlands Technologies LLC bought a new position in DENTSPLY SIRONA in the 4th quarter valued at $30,000. Parkside Financial Bank & Trust grew its position in shares of DENTSPLY SIRONA by 33.3% during the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock valued at $42,000 after purchasing an additional 292 shares in the last quarter. Finally, Anchor Investment Management LLC purchased a new stake in shares of DENTSPLY SIRONA in the fourth quarter worth $47,000. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 12th. Shareholders of record on Friday, June 28th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $0.64 annualized dividend and a yield of 2.33%. DENTSPLY SIRONA’s dividend payout ratio is currently -145.45%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.